Needham analyst Gil Blum lowered the price target on Nurix (NASDAQ: NRIX) to $28.00 (from $29.00) while maintaining a Buy ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Analyst Comments Analyst PT Change

Nurix (NRIX) PT Raised to $36 at H.C. WainwrightJanuary 29, 2025 6:39 AM Form S-8 Nurix Therapeutics, Inc. January 28, 2025 4:28 PM Nurix Therapeutics, Inc. (NRIX) Misses Q4 EPS by 7cJanuary 28, 2025 4:23 PM Form 10-K Nurix Therapeutics, Inc. For: Nov 30January 28, 2025 4:16 PM Form 8-K Nurix Therapeutics, Inc. For: Jan 28January 28, 2025 4:04 PM Nurix Therapeutics Reports Fourth Quarter and Fiscal Year 2024 Financial Results and Provides a Corporate UpdateJanuary 28, 2025 4:00 PM